(including Miguel Tábuas-Pereira)

Latest

• Faster Cortical Thinning and Surface Area Loss in Presymptomatic and Symptomatic C9orf72 Repeat Expansion Adult Carriers
• Neuronal Pentraxin 2 - A Synapse-Derived CSF Biomarker in Genetic Frontotemporal Dementia
• Plasma Glial Fibrillary Acidic Protein Is Raised in Progranulin-Associated Frontotemporal Dementia
• Age at Symptom Onset and Death and Disease Duration in Genetic Frontotemporal Dementia - An International Retrospective Cohort Study
• Lower CSF Amyloid-Beta 1-42 Predicts a Higher Mortality Rate in Frontotemporal Dementia
• Serum Neurofilament Light Chain in Genetic Frontotemporal Dementia - A Longitudinal, Multicentre Cohort Study
• Education Modulates Brain Maintenance in Presymptomatic Frontotemporal Dementia
• Functional Network Resilience to Pathology in Presymptomatic Genetic Frontotemporal Dementia decline presymptomatically
• The Inner Fluctuations of the Brain in Presymptomatic Frontotemporal Dementia - The Chronnectome Fingerprint
• Addition of the Aβ42/40 Ratio to the Cerebrospinal Fluid Biomarker Profile Increases the Predictive Value for Underlying Alzheimer's Disease Dementia in Mild Cognitive Impairment
• European Academy of Neurology - Resident and Research Fellow Section - Innovations and Future Direction in 2017
• Association Between Butyrylcholinesterase and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease Patients